Related Experiment Video
Updated: Aug 14, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of
Qingwei Zhu1, Sonia Pearson-White, Kunxin Luo
1Department of Molecular and Cell Biology, University of California, Berkeley, 94720-3204, USA.
Abstract:
Transforming growth factor beta (TGF-beta) was originally identified by virtue of its ability to induce transformation of the AKR-2B and NRK fibroblasts but was later found to be a potent inhibitor of the growth of epithelial, endothelial, and lymphoid cells. Although the growth-inhibitory pathway of TGF-beta mediated by the Smad proteins is well studied, the signaling pathway leading to the transforming activity of TGF-beta in fibroblasts is not well understood. Here we show that SnoN, a member of the Ski family of oncoproteins, is required for TGF-beta-induced proliferation and transformation of AKR-2B and NRK fibroblasts. TGF-beta induces upregulation of snoN expression in both epithelial cells and fibroblasts through a common Smad-dependent mechanism. However, a strong and prolonged activation of snoN transcription that lasts for 8 to 24 h is detected only in these two fibroblast lines. This prolonged induction is mediated by Smad2 and appears to play an important role in the transformation of both AKR-2B and NRK cells. Reduction of snoN expression by small interfering RNA or shortening of the duration of snoN induction by a pharmacological inhibitor impaired TGF-beta-induced anchorage-independent growth of AKR-2B cells. Interestingly, Smad2 and Smad3 play opposite roles in regulating snoN expression in both fibroblasts and epithelial cells. The Smad2/Smad4 complex activates snoN transcription by direct binding to the TGF-beta-responsive element in the snoN promoter, while the Smad3/Smad4 complex inhibits it through a novel Smad inhibitory site. Mutations of Smad4 that render it defective in heterodimerization with Smad3, which are found in many human cancers, convert the activity of Smad3 on the snoN promoter from inhibitory to stimulatory, resulting in increased snoN expression in cancer cells. Thus, we demonstrate a novel role of SnoN in the transforming activity of TGF-beta in fibroblasts and also uncovered a mechanism for the elevated SnoN expression in some human cancer cells.
Insights
Transforming growth factor beta (TGF-beta) uses SnoN to promote fibroblast proliferation and transformation. This involves prolonged SnoN induction via Smad2, contrasting with Smad3
Area of Science:
- Cell Biology
- Molecular Biology
- Oncology
Background:
- Transforming growth factor beta (TGF-beta) exhibits dual roles: inhibiting epithelial cell growth but inducing fibroblast transformation.
- The Smad-dependent growth-inhibitory pathway of TGF-beta is understood, yet the mechanism driving fibroblast transformation remains unclear.
- SnoN, a Ski family oncoprotein, is implicated in cellular processes but its role in TGF-beta-induced fibroblast transformation requires elucidation.
Purpose of the Study:
- To investigate the role of SnoN in TGF-beta-induced proliferation and transformation of AKR-2B and NRK fibroblasts.
- To elucidate the signaling pathways, particularly Smad protein involvement, regulating snoN expression and TGF-beta's transforming activity.
- To explore the differential roles of Smad2 and Smad3 in controlling snoN transcription and its implications in cancer.
Main Methods:
- Utilized small interfering RNA (siRNA) to reduce snoN expression and pharmacological inhibitors to modulate snoN induction duration.
- Analyzed snoN gene and protein expression levels in response to TGF-beta stimulation in fibroblasts and epithelial cells.
- Investigated Smad protein complex interactions with the snoN promoter using reporter assays and analysis of Smad4 mutations.
Main Results:
- SnoN is essential for TGF-beta-induced proliferation and transformation of AKR-2B and NRK fibroblasts.
- TGF-beta upregulates snoN expression via a common Smad-dependent pathway, with prolonged induction observed specifically in fibroblasts.
- Smad2/Smad4 activates snoN transcription, while Smad3/Smad4 inhibits it; Smad4 mutations in cancer alter this balance, increasing snoN expression.
Conclusions:
- SnoN plays a critical role in mediating the transforming activity of TGF-beta in fibroblasts.
- Prolonged Smad2-mediated snoN induction is a key mechanism underlying TGF-beta-induced fibroblast transformation.
- Dysregulation of Smad2/Smad3 interactions with Smad4 contributes to elevated snoN expression in certain human cancers.
Related Concept Videos
TGF - β Signaling Pathway
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Ras Gene
Ras is a superfamily...

